FHIR IG analytics| Package | us.nlm.vsac |
| Resource Type | ValueSet |
| Id | ValueSet-2.16.840.1.113762.1.4.1213.117.json |
| FHIR Version | R4 |
| Source | https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1213.117/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.117 |
| Version | 20240924 |
| Status | active |
| Date | 2024-09-24T01:00:40-04:00 |
| Name | ClopidogrelIngredientsAndRiskOfGIBleeding |
| Title | Clopidogrel Ingredients and Risk of GI Bleeding |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: This value sets contains CLOPIDOGREL ingredients to provide the estimate risk of GI bleeding when using the SDM tool),(Data Element Scope: The intent of this data element is to identify patients who are on clopidogrel),(Inclusion Criteria: Includes RxNorm codes (Rx CUI) for clopidogrel medications),(Exclusion Criteria: Excludes concepts that describe non-clopidogrel ingredients.) |
No resources found
| CodeSystem | |
| rxnorm | RxNorm |
No narrative content found in resource
{
"resourceType": "ValueSet",
"id": "2.16.840.1.113762.1.4.1213.117",
"meta": {
"versionId": "5",
"lastUpdated": "2024-09-24T01:00:40.000-04:00",
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail": {
"name": "Meaningful Drug Interaction Alerts Author"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2024-09-24"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2024-09-24"
}
],
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.117",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113762.1.4.1213.117"
}
],
"version": "20240924",
"name": "ClopidogrelIngredientsAndRiskOfGIBleeding",
"title": "Clopidogrel Ingredients and Risk of GI Bleeding",
"status": "active",
"date": "2024-09-24T01:00:40-04:00",
"publisher": "Meaningful Drug Interaction Alerts Steward",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US"
}
]
}
],
"purpose": "(Clinical Focus: This value sets contains CLOPIDOGREL ingredients to provide the estimate risk of GI bleeding when using the SDM tool),(Data Element Scope: The intent of this data element is to identify patients who are on clopidogrel),(Inclusion Criteria: Includes RxNorm codes (Rx CUI) for clopidogrel medications),(Exclusion Criteria: Excludes concepts that describe non-clopidogrel ingredients.)",
"compose": {
"include": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept": [
{
"code": "236991",
"display": "clopidogrel bisulfate"
},
{
"code": "32968",
"display": "clopidogrel"
}
]
}
]
},
"expansion": {
"identifier": "urn:uuid:b34eeedb-80f8-4aba-b250-a8517608f393",
"timestamp": "2025-05-23T19:20:34-04:00",
"total": 2,
"contains": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "236991",
"display": "clopidogrel bisulfate"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "32968",
"display": "clopidogrel"
}
]
}
}